Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.37 -0.55 (-3.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Sale and Maturity of Investments (2020 - 2026)

Updated

Analysis

Cullinan Therapeutics (CGEM) Sale and Maturity of Investments (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Cullinan Therapeutics 924.65 Mn 590.15 Mn - 55.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.25 Mn
Mar 31, 2026 52.55 Mn
Dec 31, 2025 42.00 Mn
Sep 30, 2025 80.00 Mn
Jun 30, 2025 131.93 Mn
Mar 31, 2025 162.65 Mn
Dec 31, 2024 184.00 Mn
Sep 30, 2024 116.68 Mn
Jun 30, 2024 139.82 Mn
Mar 31, 2024 144.33 Mn
Dec 31, 2023 117.48 Mn
Sep 30, 2023 93.82 Mn
Jun 30, 2023 93.61 Mn
Mar 31, 2023 104.48 Mn
Dec 31, 2022 132.60 Mn
Sep 30, 2022 61.40 Mn
Jun 30, 2022 67.20 Mn
Mar 31, 2022 91.73 Mn
Dec 31, 2021 61.40 Mn
Sep 30, 2021 59.71 Mn
API Access

Cullinan Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=CGEM&period=max&api_key=YOUR_API_KEY